258 related articles for article (PubMed ID: 31498474)
1. Survival and Prognosis of Chondrosarcoma Subtypes: SEER Database Analysis.
Amer KM; Munn M; Congiusta D; Abraham JA; Basu Mallick A
J Orthop Res; 2020 Feb; 38(2):311-319. PubMed ID: 31498474
[TBL] [Abstract][Full Text] [Related]
2. Survival in Mesenchymal Chondrosarcoma Varies Based on Age and Tumor Location: A Survival Analysis of the SEER Database.
Schneiderman BA; Kliethermes SA; Nystrom LM
Clin Orthop Relat Res; 2017 Mar; 475(3):799-805. PubMed ID: 26975384
[TBL] [Abstract][Full Text] [Related]
3. Identifying the Prognosis Factors and Predicting the Survival Probability in Patients with Non-Metastatic Chondrosarcoma from the SEER Database.
Huang R; Sun Z; Zheng H; Yan P; Hu P; Yin H; Zhang J; Meng T; Huang Z
Orthop Surg; 2019 Oct; 11(5):801-810. PubMed ID: 31663279
[TBL] [Abstract][Full Text] [Related]
4. Regional Lymph Node Involvement Is Associated With Poorer Survivorship in Patients With Chondrosarcoma: A SEER Analysis.
Wan L; Tu C; Li S; Li Z
Clin Orthop Relat Res; 2019 Nov; 477(11):2508-2518. PubMed ID: 31283732
[TBL] [Abstract][Full Text] [Related]
5. Dedifferentiated chondrosarcoma: A survival analysis of 159 cases from the SEER database (2001-2011).
Strotman PK; Reif TJ; Kliethermes SA; Sandhu JK; Nystrom LM
J Surg Oncol; 2017 Aug; 116(2):252-257. PubMed ID: 28420036
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology, Incidence, and Survival of Rhabdomyosarcoma Subtypes: SEER and ICES Database Analysis.
Amer KM; Thomson JE; Congiusta D; Dobitsch A; Chaudhry A; Li M; Chaudhry A; Bozzo A; Siracuse B; Aytekin MN; Ghert M; Beebe KS
J Orthop Res; 2019 Oct; 37(10):2226-2230. PubMed ID: 31161653
[TBL] [Abstract][Full Text] [Related]
7. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.
Mukherjee D; Chaichana KL; Gokaslan ZL; Aaronson O; Cheng JS; McGirt MJ
J Neurosurg Spine; 2011 Feb; 14(2):143-50. PubMed ID: 21184634
[TBL] [Abstract][Full Text] [Related]
8. Skull base chordoma and chondrosarcoma: influence of clinical and demographic factors on prognosis: a SEER analysis.
Bohman LE; Koch M; Bailey RL; Alonso-Basanta M; Lee JY
World Neurosurg; 2014 Nov; 82(5):806-14. PubMed ID: 25009165
[TBL] [Abstract][Full Text] [Related]
9. Is Chemotherapy Associated with Improved Overall Survival in Patients with Dedifferentiated Chondrosarcoma? A SEER Database Analysis.
Cranmer LD; Chau B; Mantilla JG; Loggers ET; Pollack SM; Kim TS; Kim EY; Kane GM; Thompson MJ; Harwood JL; Wagner MJ
Clin Orthop Relat Res; 2022 Apr; 480(4):748-758. PubMed ID: 34648466
[TBL] [Abstract][Full Text] [Related]
10. Does the SORG Algorithm Predict 5-year Survival in Patients with Chondrosarcoma? An External Validation.
Bongers MER; Thio QCBS; Karhade AV; Stor ML; Raskin KA; Lozano Calderon SA; DeLaney TF; Ferrone ML; Schwab JH
Clin Orthop Relat Res; 2019 Oct; 477(10):2296-2303. PubMed ID: 31107338
[TBL] [Abstract][Full Text] [Related]
11. C-reactive protein: An independent predictor for dedifferentiated chondrosarcoma.
Nemecek E; Funovics PT; Hobusch GM; Lang S; Willegger M; Sevelda F; Brodowicz T; Stihsen C; Windhager R; Panotopoulos J
J Orthop Res; 2018 Oct; 36(10):2797-2801. PubMed ID: 29701260
[TBL] [Abstract][Full Text] [Related]
12. Does Resection of the Primary Tumor Improve Survival in Patients With Metastatic Chondrosarcoma?
Song K; Song J; Chen F; Lin K; Ma X; Jiang J
Clin Orthop Relat Res; 2019 Mar; 477(3):573-583. PubMed ID: 30762691
[TBL] [Abstract][Full Text] [Related]
13. Chondrosarcoma in the United States (1973 to 2003): an analysis of 2890 cases from the SEER database.
Giuffrida AY; Burgueno JE; Koniaris LG; Gutierrez JC; Duncan R; Scully SP
J Bone Joint Surg Am; 2009 May; 91(5):1063-72. PubMed ID: 19411454
[TBL] [Abstract][Full Text] [Related]
14. Characteristics and Long-Term Outcome of Surgically Managed High-Grade Extremity Chondrosarcoma.
Gulbrandsen TR; Skalitzky MK; Russell MD; An Q; Hasan O; Miller BJ
Iowa Orthop J; 2023; 43(1):71-75. PubMed ID: 37383872
[TBL] [Abstract][Full Text] [Related]
15. Conditional Survival Analysis for Spinal Chondrosarcoma Patients After Surgical Resection.
Song K; Lin K; Guan H; Li F
Spine (Phila Pa 1976); 2020 Aug; 45(16):1110-1117. PubMed ID: 32205690
[TBL] [Abstract][Full Text] [Related]
16. Extraskeletal myxoid chondrosarcoma: Clinical features and overall survival.
Brown JM; Rakoczy K; Pretell-Mazzini J
Cancer Treat Res Commun; 2022; 31():100530. PubMed ID: 35144048
[TBL] [Abstract][Full Text] [Related]
17. Primary Tumor Resection Prolongs Survival in Spinal Chondrosarcoma Patients With Distant Metastasis.
Song K; Lin K; Kang H; Dong Y; Guan H; Li F
Spine (Phila Pa 1976); 2020 Dec; 45(24):E1661-E1668. PubMed ID: 32925686
[TBL] [Abstract][Full Text] [Related]
18. Can Machine-learning Techniques Be Used for 5-year Survival Prediction of Patients With Chondrosarcoma?
Thio QCBS; Karhade AV; Ogink PT; Raskin KA; De Amorim Bernstein K; Lozano Calderon SA; Schwab JH
Clin Orthop Relat Res; 2018 Oct; 476(10):2040-2048. PubMed ID: 30179954
[TBL] [Abstract][Full Text] [Related]
19. Chondrosarcoma of the Osseous Spine: An Analysis of Epidemiology, Patient Outcomes, and Prognostic Factors Using the SEER Registry From 1973 to 2012.
Arshi A; Sharim J; Park DY; Park HY; Bernthal NM; Yazdanshenas H; Shamie AN
Spine (Phila Pa 1976); 2017 May; 42(9):644-652. PubMed ID: 28441682
[TBL] [Abstract][Full Text] [Related]
20. [Clinical analysis of sinonasal chondrosarcoma in 47 cases].
Li WP; Lu HY; Wang H; Zhang HK; Liu Q; Sun XC; Hu L; Wang DH
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Jan; 55(1):14-20. PubMed ID: 31954383
[No Abstract] [Full Text] [Related]
[Next] [New Search]
